resTORbio
engages in the development and commercialization of novel therapeutics for the treatment of aging-related diseases... Read moreresTORbio
engages in the development and commercialization of novel therapeutics for the treatment of aging-related diseases... Read more
News
Dec 01, 2020
Zolmax News
resTORbio: Comparing resTORbio (NASDAQ:TORC) and Histogen (NASDAQ:HSTO)
Sep 16, 2020
MarketScreener
resTORbio: resTORbio : Form of prospectus reflecting facts events constituting substantive change from last form
Sep 16, 2020
MarketScreener
resTORbio: resTORbio : Investor Presentation
Sep 15, 2020
Boston Citybizlist
resTORbio: Adicet Merge with resTORbio
Jul 30, 2020
Boston Citybizlist
resTORbio: resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results
Jul 28, 2020
MarketScreener
resTORbio: resTORbio : and TrialSpark collaborate to investigate RTB-101 for COVID-19 on the Project Covalence platform
Jul 28, 2020
Seeking Alpha
resTORbio: ResTORbio nabs award to fund pilot study of RTB101 in COVID-19
Jul 17, 2020
MarketScreener
resTORbio: Rigrodsky & Long, P.A. Files Class Action Suit Against resTORbio, Inc.
Jul 05, 2020
Zolmax News
resTORbio: resTORbio, Inc. (NASDAQ:TORC) Given Average Rating of "Hold" by Brokerages
Jun 30, 2020
Virtual-Strategy Magazine
resTORbio: SHAREHOLDER ALERT: WeissLaw LLP Investigates resTORbio, Inc.
